[HTML] nih.gov

[HTML][HTML] Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - ncbi.nlm.nih.gov
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …
被引用次数：9 相关文章

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - europepmc.org
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …
[PDF] researchgate.net

[PDF][PDF] Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei, LS Zhao… - 2022 - researchgate.net
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder(BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - pubmed.ncbi.nlm.nih.gov
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - search.ebscohost.com
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

N Rong-Jun, G Tian-Hao, W Yi-Yan, T Yang… - Zoological …, 2022 - zoores.ac.cn
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei, LS Zhao… - 2022 - agris.fao.org
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - search.proquest.com
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …
[PDF] semanticscholar.org

[PDF][PDF] Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei, LS Zhao… - 2022 - pdfs.semanticscholar.org
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder(BD). Recent studies have shown that ketamine may increase …

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

RJ Ni, TH Gao, YY Wang, Y Tian, JX Wei… - Zoological …, 2022 - zoores.ac.cn
Ketamine, a rapid-acting antidepressant drug, has been used to treat major depressive
disorder and bipolar disorder (BD). Recent studies have shown that ketamine may increase …